You're signed outSign in or to get full access.
Bios Capital Management, LP
BIOS Capital Management, LP is an SEC-registered investment adviser headquartered in Fort Worth, Texas. The firm, founded in 2019, employs around 8 staff, primarily investment professionals. BIOS focuses on investments in the healthcare and biotechnology sector, managing capital for institutional investors and high-net-worth individuals, and is known for building concentrated long-term positions in emerging therapeutics and life science companies.
Investment Strategy
BIOS Capital Management adopts a science-driven, long-term investment approach focused on identifying and partnering with innovative life sciences and biotechnology companies. Their strategy emphasizes concentrated holdings in early-stage therapeutics, leveraging deep sector expertise to originate and manage investments in companies developing novel platforms, drugs, or technologies. The firm maintains a hands-on, fundamental research process and prefers higher-conviction positions in the healthcare sector.
Latest 13F Filing Activity
Bios Capital Management, LP filed their most recent 13F report on Jun 30, 2025 disclosing 5 equity positions with a total 13F market value of $73M. The fund increased holdings in Rein Therapeutics Inc., Cognition Therapeutics Inc., In8bio Inc. among other positions. Bios Capital Management, LP reduced exposure to Actuate Therapeutics Inc., Lantern Pharma Inc., In8bio Inc. among others.
Top Holdings
Equity Positions (5)
| Ticker | Security | Weight | Market Value | Shares | Avg Cost | Price | Change (QoQ) |
|---|---|---|---|---|---|---|---|
A ACTU | ACTUATE THERAPEUTICS INC | 83.89% | $60.9M | 9,965,079 | $7.95 | $6.11 | -$6.1M |
L LTRN | LANTERN PHARMA INC | 4.68% | $3.4M | 1,075,952 | $3.19 | $3.16 | -$875.3K |
R RNTX | REIN THERAPEUTICS INC | 3.26% | $2.4M | 1,690,751 | $2.30 | $1.40 | -$625.6K |
C CGTX | COGNITION THERAPEUTICS INC | 2.56% | $1.9M | 6,000,000 | $0.70 | $0.31 | -$664.8K |
I INAB | IN8BIO INC | 0.83% | $599.1K | 286,664 | $7.72 | $2.09 | -$828.5K |
Industry Allocation
Ask Fintool AI Agent
Get instant answers from SEC filings, earnings calls & more